Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapid detection of major depression in epilepsy: a multicentre study.

Frank G Gilliam1, John J Barry, Bruce P Hermann

  • 1Department of Neurology, The Neurological Institute, Columbia University, New York, USA. fgilliam@neuro.columbia.edu

The Lancet. Neurology
|April 25, 2006
PubMed
Summary

A new screening tool, the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), accurately identifies major depression in epilepsy patients. This brief instrument helps differentiate depression from medication side effects, improving patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Instrumental Activities of Daily Living in Older Adults with Epilepsy: A Cross-Sectional and Longitudinal Multicenter Study.

medRxiv : the preprint server for health sciences·2026
Same author

Alzheimer's disease neuroimaging signature aids identification of cognitive impairment in older adults with early-onset epilepsy.

medRxiv : the preprint server for health sciences·2026
Same author

The IMPACT epilepsy Consortium: Exploring social drivers of health in epilepsy care to advance solution based initiatives.

Epilepsy & behavior : E&B·2026
Same author

Utility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort Study.

medRxiv : the preprint server for health sciences·2026
Same author

Comparing normative and ipsative methods of IC-CoDE phenotype classification in frontal lobe epilepsy.

Epilepsy & behavior : E&B·2026
Same author

AT(N) Framework in Older Adults with Epilepsy: Plasma Biomarkers and Associations with Demographic, Clinical, and Cognitive Features.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Psychology

Background:

  • Depression frequently co-occurs with epilepsy but is often overlooked in routine neurological assessments.
  • Existing screening tools may not effectively distinguish depression from cognitive deficits or antiepileptic drug side effects in epilepsy patients.

Purpose of the Study:

  • To develop and validate a rapid and accurate screening instrument for major depression specifically in individuals with epilepsy.
  • To create a tool that differentiates depressive symptoms from adverse effects of antiepileptic medications.

Main Methods:

  • Developed a 46-item preliminary instrument, the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), focusing on depression symptoms distinct from epilepsy comorbidities.
  • Administered the NDDI-E and other diagnostic/severity measures to 205 adult epilepsy outpatients.

Related Experiment Videos

  • Utilized discriminant function analysis for item selection and logistic regression for model verification in a separate sample of 229 patients.

    • Main Results:

    • The final NDDI-E comprised six items, demonstrating strong internal consistency (0.85) and test-retest reliability (0.78).
    • An NDDI-E score >15 achieved 90% specificity and 81% sensitivity for major depression diagnosis.
    • The NDDI-E's diagnostic accuracy was not confounded by antiepileptic drug side effects, unlike generic depression screening instruments.

    Conclusions:

    • The NDDI-E effectively identifies major depression in epilepsy patients using a concise set of symptoms.
    • This instrument can reliably distinguish depression from common antiepileptic drug side effects.
    • The NDDI-E facilitates prompt detection and improved management of depression in epilepsy, aligning with clinical guidelines.